462 related articles for article (PubMed ID: 7675002)
1. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
Jungmann E; Carlberg C; Schallmayer M; Schumm-Draeger PM
Med Klin (Munich); 1995 Jul; 90(7):383-9. PubMed ID: 7675002
[TBL] [Abstract][Full Text] [Related]
2. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
Khan S; Qayyum S; Khan MNA
J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
[TBL] [Abstract][Full Text] [Related]
3. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus.
Amador-Licona N; Guízar-Mendoza J; Vargas E; Sánchez-Camargo G; Zamora-Mata L
Arch Med Res; 2000; 31(6):571-5. PubMed ID: 11257323
[TBL] [Abstract][Full Text] [Related]
4. Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin.
Nielsen S; Schmitz A; Bacher T; Rehling M; Ingerslev J; Mogensen CE
Diabetologia; 1999 Jan; 42(1):60-7. PubMed ID: 10027580
[TBL] [Abstract][Full Text] [Related]
5. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
[TBL] [Abstract][Full Text] [Related]
6. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.
Park JY; Kim HK; Chung YE; Kim SW; Hong SK; Lee KU
Diabetes Care; 1998 Apr; 21(4):530-4. PubMed ID: 9571337
[TBL] [Abstract][Full Text] [Related]
7. Renal involvement in type 1 (IDDM) diabetes in Spain. ESTUDIO DIAMANTE.
Diabetes Res Clin Pract; 1997 Nov; 38(2):129-37. PubMed ID: 9483377
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of elevated urinary albumin excretion rate in type 2 diabetic patients suffering from ischemic foot lesions.
Zander E; Heinke P; Gottschling D; Zander G; Strese J; Herfurth S; Michaelis D
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():51-3. PubMed ID: 9288546
[TBL] [Abstract][Full Text] [Related]
9. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.
Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE
Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066
[TBL] [Abstract][Full Text] [Related]
10. Microalbuminuria and clinical correlates in black African patients with type 2 diabetes.
Adetunji OR; Adeleye JO; Agada NO; Salako BL
West Afr J Med; 2006; 25(4):279-83. PubMed ID: 17402516
[TBL] [Abstract][Full Text] [Related]
11. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
Estacio RO; Coll JR; Tran ZV; Schrier RW
Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
[TBL] [Abstract][Full Text] [Related]
12. Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria.
Nakamura T; Ushiyama C; Suzuki S; Shimada N; Sekizuka K; Ebihara L; Koide H
Diabet Med; 2001 Apr; 18(4):308-13. PubMed ID: 11437862
[TBL] [Abstract][Full Text] [Related]
13. Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria.
Rossing K; Schjoedt KJ; Jensen BR; Boomsma F; Parving HH
Kidney Int; 2005 Sep; 68(3):1190-8. PubMed ID: 16105050
[TBL] [Abstract][Full Text] [Related]
14. High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects.
Lee IT; Wang CY; Huang CN; Fu CC; Sheu WH
J Diabetes Complications; 2013; 27(3):243-7. PubMed ID: 23276621
[TBL] [Abstract][Full Text] [Related]
15. Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease.
Kobayashi K; Toyoda M; Kaneyama N; Hatori N; Furuki T; Sakai H; Takihata M; Umezono T; Ito S; Suzuki D; Takeda H; Kanamori A; Degawa H; Yamamoto H; Machimura H; Mokubo A; Chin K; Obana M; Hishiki T; Aoyama K; Nakajima S; Umezawa S; Shimura H; Aoyama T; Miyakawa M
J Diabetes Res; 2019; 2019():9415313. PubMed ID: 31781668
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of ibudilast on urinary albumin excretion in type 2 diabetes mellitus with microalbuminuria.
Hoshino T; Ikeda T
Nephron; 2002 Feb; 90(2):154-7. PubMed ID: 11818699
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective.
Pan CY; Ho LT; Soegondo S; Prodjosudjadi W; Suwanwalaikorn S; Lim SC; Chan TM; Chow KW; Thoenes M; Choi DS;
Diabetes Technol Ther; 2008 Oct; 10(5):397-403. PubMed ID: 18715217
[TBL] [Abstract][Full Text] [Related]
18. Rate of progression of albuminuria in type II diabetes. Five-year prospective study from south India.
John L; Rao PS; Kanagasabapathy AS
Diabetes Care; 1994 Aug; 17(8):888-90. PubMed ID: 7956637
[TBL] [Abstract][Full Text] [Related]
19. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
Yokoyama H; Jensen JS; Jensen T; Deckert T
J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
[TBL] [Abstract][Full Text] [Related]
20. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
